Caroline Rönnlund

Artiklar

Article: BREAST CANCER RESEARCH. 2024;26(1):24
Prognostic impact of HER2 biomarker levels in trastuzumab-treated early HER2-positive breast cancer
Ronnlund C; Sifakis EG; Schagerholm C; Yang Q; Karlsson E; Chen X; Foukakis T; Weidler J; Bates M; Fredriksson I; Robertson S; Hartman J
Article: JOURNAL OF NUCLEAR MEDICINE. 2023;64(9):1364-1370
Human Epidermal Growth Factor Receptor 2-Targeting [⁶⁸Ga]Ga-ABY-025 PET/CT Predicts Early Metabolic Response in Metastatic Breast Cancer
Alhuseinalkhudhur A; Lindman H; Liss P; Sundin T; Frejd FY; Hartman J; Iyer V; Feldwisch J; Lubberink M; Ronnlund C; Tolmachev V; Velikyan I; Sorensen J
Article: CANCERS. 2021;13(5):1166
Variability in Breast Cancer Biomarker Assessment and the Effect on Oncological Treatment Decisions: A Nationwide 5-Year Population-Based Study
Acs B; Fredriksson I; Ronnlund C; Hagerling C; Ehinger A; Kovacs A; Roge R; Bergh J; Hartman J
Article: BREAST CANCER RESEARCH AND TREATMENT. 2019;174(3):795-805
Re-testing of predictive biomarkers on surgical breast cancer specimens is clinically relevant
Robertson S; Ronnlund C; de Boniface J; Hartman J
Article: JOURNAL OF ENDOCRINOLOGY. 2009;200(3):311-319
Estrogen-dependent downregulation of hairy and enhancer of split homolog-1 gene expression in breast cancer cells is mediated via a 3′ distal element
Muller P; Merrell KW; Crofts JD; Ronnlund C; Lin C-Y; Gustafsson J-A; Strom A